A new study published Tuesday in the peer-reviewed JAMA Cardiology journal reported a “higher than expected” number of myocarditis cases among male military members after the second dose of an mRNA vaccine against the CCP (Chinese Communist Party) virus. The new study, a retrospective review of cases, noted that the observed number of cases of myocarditis—inflammation of the heart muscle—was still “relatively small.” The case review involved patients in the U.S. military health system who experienced myocarditis after they received an mRNA vaccine dose for COVID-19—the disease caused by the CCP virus—between Jan. 1 and April 30. It found that 23 males presented with “acute onset of marked chest pain” within four days of receiving a vaccine dose. Seven received the Pfizer-BioNTech vaccine and 16 received the Moderna vaccine, both of which use messenger RNA (mRNA) technology. The group’s age ranged 20-51, with a median of 25. All “had a final diagnosis of myocarditis without infectious, …